Linkedin X-twitter Youtube
Launch Digital Edition

Webinars and Sponsored Roundtables — Register Now

Tuesday, April 28, 2026, 12:00 PM–1:00 PM ET
Discover how next-day comprehensive genomic profiling (CGP) is possible with the Oncomine Comprehensive Assay Plus on the Genexus System—delivering both speed and accuracy.

Webinar presenters Jane Bayani, MHSc, PhD, Assistant Professor and Co-Director, Diagnostic Development, Ontario Institute for Cancer Research, Canada, and Nicola Normanno, MD, Scientific Director, IRCCS Romagnolo Institute for the Study of Tumors, Italy, and Morten Grauslund, PhD, Molecular Biologist, Department of Pathology, Rigshospitalet/Copenhagen University Hospital, Copenhagen, Denmark.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Thermo Fisher Scientific. For Research Use Only. Not for use in diagnostic applications. 

Register Now

Thursday, April 30, 2026, 11:00 AM–12:00 PM ET
Hear an expert discuss how Memorial Sloan Kettering Cancer Center (MSKCC) is utilizing
the oncoReveal® Nexus 21-gene panel to redefine turnaround time and actionable insights
in cancer care. Dr. Ewalt shares a perceptive look at the clinical need for rapid, front-line NGS sequencing, and how a unique, purpose built targeted NGS panel (Pillar Biosciences’ oncoReveal Nexus 21 gene Panel) was developed, validated and implemented clinically by Memorial Sloan Kettering Cancer Center (MSK-REACT) to complement their current comprehensive genomic profiling (CGP) approach.

Webinar presenter Mark Ewalt, MD, Associate Medical Director for Laboratory Operations for Diagnostic Molecular Pathology in the Molecular Diagnostics Service, Department of Pathology and Laboratory Medicine, MSKCC.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Pillar Biosciences.

Register Now

Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.

Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy,  CEO of mTuitive.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Register Now

Subspecialties

Interactive Product Guides

Marketplace

Ortho, Brahms agreement, 9/17

September 2017—Ortho Clinical Diagnostics announced a strategic relationship with Brahms GmbH, part of Thermo Fisher Scientific, to develop the Brahms PCT assay for use on Ortho’s Vitros Systems. The Brahms PCT assay is used in conjunction with other laboratory findings and clinical assessment to aid in sepsis management, including early identification of patients at higher risk of progressing to septic shock, identifying when it is safe to discontinue antibiotics, and establishing mortality risk in septic patients.

Streck distribution agreements, 9/17

September 2017—Streck and Inter Medico, a privately owned Canadian distributor of medical diagnostic and research-related products, have signed a distribution agreement for Streck’s cell stabilization and molecular products. Inter Medico will have exclusive distribution rights in Canada to those Streck products.

FDA-approved tests for Roche instruments, 9/17

September 2017—Roche received FDA approval for the Cobas CMV test for use on its Cobas 6800 and Cobas 8800 Systems. The test is standardized to the 1st WHO International Standard for improving harmonization in cytomegalovirus testing results across hospital institutions.

Bio-Rad quality controls, 9/17

September 2017—Bio-Rad Laboratories has added four analytes to the company’s Liquichek Tumor Marker Control. The updated control received FDA 510(k) clearance and the CE mark and is available for the immunoassay-based tumor marker testing market.

Hematology analyzer, 9/17

September 2017—Diatron displayed its Aquila three-part differential hematology analyzer at the 69th AACC annual meeting in San Diego. Specifically designed for the decentralized laboratory, this small analyzer has low reagent consumption of less than 12 mL, requires less than 20 µL of whole blood, and has a throughput of up to 60 samples per hour.

Full chemistry menu for BioLis 24i instrument, 9/17

September 2017—MedTest’s Pointe Scientific product brand has developed a full line of chemistry reagents that are manufactured and packaged in barcoded reagent containers for use on the BioLis 24i chemistry analyzer, also known as the CLC480 or MGC 240 chemistry analyzer.

Singulex assay development, 9/17

September 2017—Singulex is developing an ultra-sensitive Clostridium difficile toxin A/B assay for use on its Sgx Clarity system, a fully automated, in vitro diagnostics platform powered by single-molecule counting technology.

IL launches GemWeb Plus 500, 9/17

September 2017—Instrumentation Laboratory launched its customized connectivity solution, GemWeb Plus 500. From its dashboard, GemWeb Plus 500 offers complete control of Gem Premier critical care testing systems, including Gem Premier 5000 with Intelligent Quality Management 2, as well as connectivity to non-IL-manufactured devices at the point of care. GemWeb Plus 500 is accessible from tablet devices, PCs, and any networked analyzer.

Bacterial cultivation system, 9/17

September 2017—Advanced Instruments displayed its newly launched Anoxomat III at the 69th AACC Annual Scientific Meeting and Clinical Lab Expo in San Diego.

Ultra-sensitive POC test for GFAP, 9/17

September 2017—Dx-Sys has developed an ultra-sensitive, lateral flow point-of-care diagnostic test for glial fibrillary acidic protein, a potential biomarker for traumatic brain injury.

MARKETPLACE

TRENDING